Artificial Intelligence (AI) has once again secured a spot on the Eurasia Group’s list of top geopolitical risks, ranking eighth for 2025. While AI offers groundbreaking opportunities, the report warns of significant challenges as regulatory frameworks struggle to keep pace with…
Connecticut Likely to Consider AI Regulation this Legislative Session
State Sen. James Maroney, a leading voice for AI regulation, is optimistic about passing a new bill aimed at protecting residents from potentially harmful and discriminatory uses of algorithms. Last year’s proposed legislation faced challenges, but Maroney believes 2025 offers a…
The FDA has shared draft guidance on using AI for regulatory decisions in drug and biologic products.
The FDA has released a draft titled “Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products”. This document outlines key recommendations for using AI in regulatory decisions, ensuring safety, transparency, and accuracy in drug…